Syngene International Expands Capabilities
Syngene International, a global contract research, development and manufacturing organization, is adding a GMP bioconjugation suite at its commercial biologics facility in Bengaluru.
This new capability will complement its existing services, including commercial payload, linker, and monoclonal antibodies, to offer fully integrated, end-to-end services for antibody-drug conjugates (ADCs) development.
With this expansion, Syngene will be among a handful of CDMOs with full-service capabilities, providing services from discovery through to GMP manufacturing.
Syngene International is adding a GMP bioconjugation suite to offer fully integrated services for ADCs development.
Author's summary: Syngene International expands its capabilities.
More News
- Disney World guest rescues collapsed man in latest medical emergency
- [Commissioner Dexter McCoy launches bid for Fort Bend County judge, citing need for new leadership]
- One Of EVE Online's Biggest Alliances Has Collapsed While EVE Player Numbers Surge
- Rapala x Charlie's Fishing Limited Edition Super Shadow Rap Glide 11
- Fort Bend Commissioner Dexter McCoy joins 2026 county judge race
- MCCOY definition and meaning | Collins English Dictionary
- Cienega Fine Arts Showcase 2025 Highlights
- Erika Kirk on gun violence being root problem that led to Charlie's murder, ‘I support the…’ | Hindustan Times
- Fifth time's a charm for Mica Mountain football coach Jay Campos
- From 2600% gain to 86% wipeout, crypto’s hottest trade collapsed